Thomas S. Guillot - Publications

Affiliations: 
Emory University, Atlanta, GA 

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Stout KA, Dunn AR, Lohr KM, Alter SP, Cliburn RA, Guillot TS, Miller GW. Selective enhancement of dopamine release in the ventral pallidum of methamphetamine-sensitized mice. Acs Chemical Neuroscience. PMID 27501345 DOI: 10.1021/acschemneuro.6b00131  0.92
2015 Alter SP, Stout KA, Lohr KM, Taylor TN, Shepherd KR, Wang M, Guillot TS, Miller GW. Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degeneration. Experimental Neurology. PMID 26428905 DOI: 10.1016/j.expneurol.2015.09.016  0.92
2015 Lohr KM, Stout KA, Dunn AR, Wang M, Salahpour A, Guillot TS, Miller GW. Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity. Acs Chemical Neuroscience. 6: 790-9. PMID 25746685 DOI: 10.1021/acschemneuro.5b00010  0.92
2015 Richardson JR, Taylor MM, Shalat SL, Guillot TS, Caudle WM, Hossain MM, Mathews TA, Jones SR, Cory-Slechta DA, Miller GW. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1960-72. PMID 25630971 DOI: 10.1096/fj.14-260901  0.92
2014 Lohr KM, Bernstein AI, Stout KA, Dunn AR, Lazo CR, Alter SP, Wang M, Li Y, Fan X, Hess EJ, Yi H, Vecchio LM, Goldstein DS, Guillot TS, Salahpour A, et al. Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proceedings of the National Academy of Sciences of the United States of America. 111: 9977-82. PMID 24979780 DOI: 10.1073/pnas.1402134111  0.92
2013 Dhurandhar E, Leblanc M, Rebello C, Caruso-Davis M, Guillot T, Bissoon L, Greenway F. Thigh girth loss in women with lower body fat distribution increases breast volume Plastic and Reconstructive Surgery. 132: 483e-484e. PMID 23985677 DOI: 10.1097/PRS.0b013e31829ad4a3  0.92
2013 Jayasinghe S, Guillot T, Bissoon L, Greenway F. Mesotherapy for local fat reduction Obesity Reviews. 14: 780-791. PMID 23800269 DOI: 10.1111/obr.12049  0.92
2012 Caudle WM, Guillot TS, Lazo C, Miller GW. Parkinson's disease and the environment: beyond pesticides. Neurotoxicology. 33: 585. PMID 22774228 DOI: 10.1016/j.neuro.2012.04.011  0.92
2012 Kile BM, Walsh PL, McElligott ZA, Bucher ES, Guillot TS, Salahpour A, Caron MG, Wightman RM. Optimizing the Temporal Resolution of Fast-Scan Cyclic Voltammetry. Acs Chemical Neuroscience. 3: 285-292. PMID 22708011 DOI: 10.1021/cn200119u  0.92
2012 Caudle WM, Guillot TS, Lazo CR, Miller GW. Industrial toxicants and Parkinson's disease. Neurotoxicology. 33: 178-88. PMID 22309908 DOI: 10.1016/j.neuro.2012.01.010  0.92
2011 Hashemi P, Walsh PL, Guillot TS, Gras-Najjar J, Takmakov P, Crews FT, Wightman RM. Chronically Implanted, Nafion-Coated Ag/AgCl Reference Electrodes for Neurochemical Applications. Acs Chemical Neuroscience. 2: 658-666. PMID 22125666 DOI: 10.1021/cn2000684  0.92
2011 Street SE, Walsh PL, Sowa NA, Taylor-Blake B, Guillot TS, Vihko P, Wightman RM, Zylka MJ. PAP and NT5E inhibit nociceptive neurotransmission by rapidly hydrolyzing nucleotides to adenosine. Molecular Pain. 7: 80. PMID 22011440 DOI: 10.1186/1744-8069-7-80  0.92
2011 Redman LM, Moro C, Dobak J, Yu Y, Guillot TS, Greenway FL. Association of β-2 adrenergic agonist and corticosteroid injection in the treatment of lipomas. Diabetes, Obesity & Metabolism. 13: 517-22. PMID 21272189 DOI: 10.1111/j.1463-1326.2011.01374.x  0.92
2011 Caruso-Davis MK, Guillot TS, Podichetty VK, Mashtalir N, Dhurandhar NV, Dubuisson O, Yu Y, Greenway FL. Efficacy of low-level laser therapy for body contouring and spot fat reduction. Obesity Surgery. 21: 722-9. PMID 20393809 DOI: 10.1007/s11695-010-0126-y  0.92
2010 Kile BM, Guillot TS, Venton BJ, Wetsel WC, Augustine GJ, Wightman RM. Synapsins differentially control dopamine and serotonin release. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9762-70. PMID 20660258 DOI: 10.1523/JNEUROSCI.2071-09.2010  0.92
2009 Guillot TS, Miller GW. Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Molecular Neurobiology. 39: 149-70. PMID 19259829 DOI: 10.1007/s12035-009-8059-y  0.92
2008 Guillot TS, Asress SA, Richardson JR, Glass JD, Miller GW. Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. Journal of Motor Behavior. 40: 568-77. PMID 18980909 DOI: 10.3200/JMBR.40.6.568-577  0.92
2008 Guillot TS, Shepherd KR, Richardson JR, Wang MZ, Li Y, Emson PC, Miller GW. Reduced vesicular storage of dopamine exacerbates methamphetamine-induced neurodegeneration and astrogliosis. Journal of Neurochemistry. 106: 2205-17. PMID 18643795 DOI: 10.1111/j.1471-4159.2008.05568.x  0.92
2008 Guillot TS, Richardson JR, Wang MZ, Li YJ, Taylor TN, Ciliax BJ, Zachrisson O, Mercer A, Miller GW. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides. 42: 423-34. PMID 18533255 DOI: 10.1016/j.npep.2008.04.003  0.92
2008 Caruso MK, Roberts AT, Bissoon L, Self KS, Guillot TS, Greenway FL. An evaluation of mesotherapy solutions for inducing lipolysis and treating cellulite. Journal of Plastic, Reconstructive & Aesthetic Surgery : Jpras. 61: 1321-4. PMID 17954040 DOI: 10.1016/j.bjps.2007.03.039  0.92
2007 Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8138-48. PMID 17652604 DOI: 10.1523/JNEUROSCI.0319-07.2007  0.92
2007 Greenway FL, Liu Z, Yu Y, Caruso MK, Roberts AT, Lyons J, Schwimer JE, Gupta AK, Bellanger DE, Guillot TS, Woltering EA. An assay to measure angiogenesis in human fat tissue. Obesity Surgery. 17: 510-5. PMID 17608264 DOI: 10.1007/s11695-007-9089-z  0.92
2007 Hatcher JM, Richardson JR, Guillot TS, McCormack AL, Di Monte DA, Jones DP, Pennell KD, Miller GW. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Experimental Neurology. 204: 619-30. PMID 17291500 DOI: 10.1016/j.expneurol.2006.12.020  0.92
2007 Richardson JR, Caudle WM, Guillot TS, Watson JL, Nakamaru-Ogiso E, Seo BB, Sherer TB, Greenamyre JT, Yagi T, Matsuno-Yagi A, Miller GW. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicological Sciences : An Official Journal of the Society of Toxicology. 95: 196-204. PMID 17038483 DOI: 10.1093/toxsci/kfl133  0.92
2006 Caudle WM, Richardson JR, Delea KC, Guillot TS, Wang M, Pennell KD, Miller GW. Polychlorinated biphenyl-induced reduction of dopamine transporter expression as a precursor to Parkinson's disease-associated dopamine toxicity. Toxicological Sciences : An Official Journal of the Society of Toxicology. 92: 490-9. PMID 16702228 DOI: 10.1093/toxsci/kfl018  0.92
2006 Caruso MK, Guillot TS, Nguyen T, Greenway FL. The cost effectiveness of three different measures of breast volume. Aesthetic Plastic Surgery. 30: 16-20. PMID 16411159 DOI: 10.1007/s00266-004-0105-6  0.92
2006 Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicology and Applied Pharmacology. 211: 188-97. PMID 16005927 DOI: 10.1016/j.taap.2005.06.003  0.92
2002 Hawkins MF, Uzelac SM, Baumeister AA, Hearn JK, Broussard JI, Guillot TS. Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI. Pharmacology, Biochemistry, and Behavior. 73: 537-44. PMID 12151027  0.56
2002 Hawkins MF, Uzelac SM, Baumeister AA, Hearn JK, Broussard JI, Guillot TS. Behavioral responses to stress following central and peripheral injection of the 5-HT2 agonist DOI Pharmacology Biochemistry and Behavior. 73: 537-544. DOI: 10.1016/S0091-3057(02)00822-5  0.92
Show low-probability matches.